Lundin P - Search Results

1

A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.

Mäe M, El Andaloussi S, Lundin P, Oskolkov N, Johansson HJ, Guterstam P, Langel U. Mäe M, et al. Among authors: lundin p. J Control Release. 2009 Mar 19;134(3):221-7. doi: 10.1016/j.jconrel.2008.11.025. Epub 2008 Dec 6. J Control Release. 2009. PMID: 19105971

2

Distinct uptake routes of cell-penetrating peptide conjugates.

Lundin P, Johansson H, Guterstam P, Holm T, Hansen M, Langel U, EL Andaloussi S. Lundin P, et al. Bioconjug Chem. 2008 Dec;19(12):2535-42. doi: 10.1021/bc800212j. Bioconjug Chem. 2008. PMID: 19012426

3

Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.

Andaloussi SE, Lehto T, Lundin P, Langel U. Andaloussi SE, et al. Among authors: lundin p. Methods Mol Biol. 2011;683:361-73. doi: 10.1007/978-1-60761-919-2_26. Methods Mol Biol. 2011. PMID: 21053143

4

Toxicity methods for CPPs.

Lundin P, Andaloussi SE, Langel U. Lundin P, et al. Methods Mol Biol. 2011;683:195-205. doi: 10.1007/978-1-60761-919-2_14. Methods Mol Biol. 2011. PMID: 21053131

5

A peptide-based vector for efficient gene transfer in vitro and in vivo.

Lehto T, Simonson OE, Mäger I, Ezzat K, Sork H, Copolovici DM, Viola JR, Zaghloul EM, Lundin P, Moreno PM, Mäe M, Oskolkov N, Suhorutšenko J, Smith CI, Andaloussi SE. Lehto T, et al. Among authors: lundin p. Mol Ther. 2011 Aug;19(8):1457-67. doi: 10.1038/mt.2011.10. Epub 2011 Feb 22. Mol Ther. 2011. PMID: 21343913 Free PMC article.

6

Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles.

Gupta D, Wiklander OPB, Görgens A, Conceição M, Corso G, Liang X, Seow Y, Balusu S, Feldin U, Bostancioglu B, Jawad R, Mamand DR, Lee YXF, Hean J, Mäger I, Roberts TC, Gustafsson M, Mohammad DK, Sork H, Backlund A, Lundin P, de Fougerolles A, Smith CIE, Wood MJA, Vandenbroucke RE, Nordin JZ, El-Andaloussi S. Gupta D, et al. Among authors: lundin p. Nat Biomed Eng. 2021 Sep;5(9):1084-1098. doi: 10.1038/s41551-021-00792-z. Epub 2021 Oct 6. Nat Biomed Eng. 2021. PMID: 34616047

7

Circular RNA interference effector molecules (WO10084371).

Lundin P, Moreno PM, Smith CI, Andaloussi SE. Lundin P, et al. Expert Opin Ther Pat. 2011 Jan;21(1):115-9. doi: 10.1517/13543776.2011.534460. Epub 2010 Nov 26. Expert Opin Ther Pat. 2011. PMID: 21110768

8

Engineered extracellular vesicle decoy receptor-mediated modulation of the IL6 trans-signalling pathway in muscle.

Conceição M, Forcina L, Wiklander OPB, Gupta D, Nordin JZ, Vrellaku B, McClorey G, Mäger I, Gӧrgens A, Lundin P, Musarò A, Wood MJA, Andaloussi SE, Roberts TC. Conceição M, et al. Among authors: lundin p. Biomaterials. 2021 Jan;266:120435. doi: 10.1016/j.biomaterials.2020.120435. Epub 2020 Oct 5. Biomaterials. 2021. PMID: 33049461

9

Clostridial translocation peptides for promoting endosomal escape of RNAi agents (WO09083738).

Lundin P. Lundin P. Expert Opin Ther Pat. 2010 Jul;20(7):975-80. doi: 10.1517/13543776.2010.487865. Expert Opin Ther Pat. 2010. PMID: 20497045

10

Is silence still golden? Mapping the RNAi patent landscape.

Lundin P. Lundin P. Nat Biotechnol. 2011 Jun 7;29(6):493-7. doi: 10.1038/nbt.1885. Nat Biotechnol. 2011. PMID: 21654666 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters